Director's Messages

Director's Messages

Subscribe to Director's Messages: National Institute of Neurological Disorders and Stroke (NINDS)RSS

Tracking Gene Mutations across the Lifespan: the Somatic Mosaicism Across Human Tissues (SMaHT) Network

(Thursday, April 28, 2022)
Each of us is born with a unique genome made up of DNA that we inherit, and changes to that DNA sequence occur in individual cells over our lifetimes.

NINDS Recognizes 2022 Women’s History Month: Vital contributions of women to science

(Tuesday, March 29, 2022)
March is Women’s History Month – a time to commemorate women’s vital contributions to our history and progress as a nation. At NIH and NINDS, March is an opportunity to celebrate women at all career stages as scientists, innovators, and leaders.

Brain Awareness Week 2022: Weeklong celebration helps the public learn the importance of the brain and brain research

(Tuesday, March 22, 2022)
Last week, we celebrated the most mysterious and fascinating organ in the body—the brain! —by participating in Brain Awareness Week, March 14-20.

NINDS recognizes 2022 Black History Month: A time to celebrate and reflect

(Wednesday, February 23, 2022)
This year marks the 47th annual celebration of Black History Month. This month, across NIH and NINDS, we recognize the contributions of the Black community to science and to our society.

Inviting your input: fostering research in fundamental neuroscience

(Wednesday, February 2, 2022)
The value of fundamental neuroscience cannot be overstated enough. Since the discoveries of Santiago Ramón y Cajal well over a century ago, basic neuroscience research has continuously advanced our understanding of the workings of the nervous system.

Hope and perseverance in our communities: Looking back on 2021

(Tuesday, January 18, 2022)
With each new year comes possibility and promise. The challenges we have faced in 2021 continue to test our grit and in some ways, our patience.

New Opportunities for Advancing Pain Science

(Wednesday, December 29, 2021)
From the Hippocratic corpus, the author writes, “I consider the responsibility of medicine to be to entirely relieve the suffering of the sick and to blunt the extremities of disease” (The Art 3.4-7)1. Note that despite the acknowledgement that disease may only be blunted, in promoting health it is our duty to relieve suffering wherever possible.

NINDS launches URGenT: A network to accelerate the development of treatments for ultra-rare neurological diseases

(Thursday, December 2, 2021)
In the United States, rare and ultra-rare diseases are defined as conditions that affect fewer than 200,000 or 6,000 people, respectively. While these numbers may seem small, they add up to a large burden: collectively, nearly 30 million Americans are living with one of the roughly 7,000 known rare or ultra-rare diseases.

NINDS Recognizes Hispanic Heritage Month

(Wednesday, October 13, 2021)
At NINDS, we anchor our efforts and activities on our mission statement: seeking fundamental knowledge about the brain and nervous system, and using that knowledge to reduce the burden of neurological disease for all people. I have been reflecting on that last clause often lately: for all people.

Spurring innovative research toward ALS cures through Accelerating Leading-edge Science in ALS (ALS2)

(Tuesday, October 5, 2021)
Neurodegenerative diseases result from progressive damage to cells and connections in the brain, spinal cord and nerves, impairing a person’s ability to move, think, communicate, or feel, and often ultimately lead to death.